140 related articles for article (PubMed ID: 24420154)
1. TERT rs2736100T/G polymorphism upregulates interleukin 6 expression in non-small cell lung cancer especially in adenocarcinoma.
Wang F; Fu P; Pang Y; Liu C; Shao Z; Zhu J; Li J; Wang T; Zhang X; Liu J
Tumour Biol; 2014 May; 35(5):4667-72. PubMed ID: 24420154
[TBL] [Abstract][Full Text] [Related]
2. Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: evidence from a case-control study of non-small-cell lung cancer and a meta-analysis.
Wu H; Qiao N; Wang Y; Jiang M; Wang S; Wang C; Hu L
PLoS One; 2013; 8(11):e76372. PubMed ID: 24260099
[TBL] [Abstract][Full Text] [Related]
3. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY
J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 17A polymorphism elevates gene expression and is associated with increased risk of nonsmall cell lung cancer.
Cheng S; Shao Z; Liu X; Guo L; Zhang X; Na Q; Chen X; Ma Y; Zheng J; Song B; Liu J
DNA Cell Biol; 2015 Jan; 34(1):63-8. PubMed ID: 25289477
[TBL] [Abstract][Full Text] [Related]
5. Ethnicity-specific association between TERT rs2736100 (A > C) polymorphism and lung cancer risk: a comprehensive meta-analysis.
Wu X; Huang G; Li W; Chen Y
Sci Rep; 2023 Aug; 13(1):13271. PubMed ID: 37582820
[TBL] [Abstract][Full Text] [Related]
6. Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India.
Bhat GR; Bhat A; Verma S; Sethi I; Shah R; Sharma V; Dar KA; Abrol D; Kaneez S; Kaul S; Ganju R; Kumar R
BMC Cancer; 2019 May; 19(1):493. PubMed ID: 31126249
[TBL] [Abstract][Full Text] [Related]
7. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population.
Zhong R; Liu L; Zou L; Zhu Y; Chen W; Zhu B; Shen N; Rui R; Long L; Ke J; Lu X; Zhang T; Zhang Y; Wang Z; Liu L; Sun Y; Cheng L; Miao X
Mol Carcinog; 2013 Nov; 52 Suppl 1():E118-26. PubMed ID: 23908149
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
10. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 17A genetic variations and susceptibility to non-small cell lung cancer.
Ma QY; Chen J; Wang SH; Wu N; Hao ZH; Chen XF
APMIS; 2015 Mar; 123(3):194-8. PubMed ID: 25469655
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population.
Zhao MM; Zhang Y; Shen L; Ren YW; Li XL; Yin ZH; Zhou BS
Asian Pac J Cancer Prev; 2014; 15(6):2809-13. PubMed ID: 24761905
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
[TBL] [Abstract][Full Text] [Related]
14. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
[TBL] [Abstract][Full Text] [Related]
15. Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China.
Lan Q; Cawthon R; Gao Y; Hu W; Hosgood HD; Barone-Adesi F; Ji BT; Bassig B; Chow WH; Shu X; Cai Q; Xiang Y; Berndt S; Kim C; Chanock S; Zheng W; Rothman N
PLoS One; 2013; 8(3):e59230. PubMed ID: 23555636
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer.
Seifart C; Plagens A; Dempfle A; Clostermann U; Vogelmeier C; von Wichert P; Seifart U
Dis Markers; 2005; 21(3):157-65. PubMed ID: 16276011
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer--a case-control study in a Chinese population.
Myneni AA; Chang SC; Niu R; Liu L; Ochs-Balcom HM; Li Y; Zhang C; Zhao B; Shi J; Han X; Li J; Su J; Cai L; Yu S; Zhang ZF; Mu L
Lung Cancer; 2013 May; 80(2):131-7. PubMed ID: 23433592
[TBL] [Abstract][Full Text] [Related]
18. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.
Sunaga N; Kohno T; Yanagitani N; Sugimura H; Kunitoh H; Tamura T; Takei Y; Tsuchiya S; Saito R; Yokota J
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):730-8. PubMed ID: 12163326
[TBL] [Abstract][Full Text] [Related]
20. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes.
Kohno T; Kunitoh H; Shimada Y; Shiraishi K; Ishii Y; Goto K; Ohe Y; Nishiwaki Y; Kuchiba A; Yamamoto S; Hirose H; Oka A; Yanagitani N; Saito R; Inoko H; Yokota J
Carcinogenesis; 2010 May; 31(5):834-41. PubMed ID: 20061363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
